Filing Flows › Voyager Therapeutics (VYGR) › How it makes money
How Voyager Therapeutics (VYGR) makes money
Voyager Therapeutics (VYGR) made $4.0M of revenue in the third quarter 2026 (Q3 2026), -70% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $4.0M | 100.0% |
| Income tax | $18K | 0.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $4.0M | -70% |
| Q2 2026 | $3.2M | -39% |
| Q1 2026 | $2.6M | -60% |
| Q4 2025 | $15.3M | +144% |
| Q3 2025 | $13.4M | -46% |
| Q2 2025 | $5.2M | -82% |
| Q1 2025 | $6.5M | -67% |
From Voyager Therapeutics' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Voyager Therapeutics make money?
Voyager Therapeutics (VYGR) made $4.0M of revenue in the third quarter 2026 (Q3 2026), -70% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.